Conversio Health, a The Woodlands, TX provider of integrated care management services focused on treating patients with complex, chronic respiratory conditions, received a strategic investment from Heritage Group.
The amount of the transaction was not disclosed. In conjunction with the investment, Rock Morphis, managing director at Heritage Group, has joined Conversio’s board of directors.
The company intends to use the funds to grow relationships with partners including health plans, employers and government agencies.
Led by Kirk Clove, CEO, Conversio Health is a healthcare services company focused on the treatment of patients with complex chronic respiratory conditions, such as asthma and chronic obstructive pulmonary disease (COPD). The company’s pharmacy-based model provides services, including targeted medical therapies as well as supplies and home delivery services. Its RITEMed™ program provides patients with access to a team of clinical pharmacists, nurse care managers, respiratory care practitioners, complex care coordinators and nutritionists.